Clinical Trial Update: The Dynamic Monitoring of Cerebrospinal Fluid ctDNA [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating dynamic monitoring of cerebrospinal fluid ctDNA in non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Jiangsu Province Nanjing Brain Hospital | Conditions: NSCLC | Phase 2 | Status: UNKNOWN